TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Fidia Spa ( (IT:FDA) ) has shared an update.
Fidia S.p.A. announced the issuance and subscription of a tranche of convertible bonds with attached warrants by Global Growth Holding Limited, amounting to a nominal value of Euro 750,000. Additionally, 10 bonds were converted into new Fidia shares, resulting in an increase in the company’s share capital and total number of shares. This financial maneuver is part of Fidia’s strategy to enhance its capital structure and market position, potentially impacting its stakeholders by increasing the liquidity and marketability of its shares.
The most recent analyst rating on (IT:FDA) stock is a Sell with a EUR0.50 price target. To see the full list of analyst forecasts on Fidia Spa stock, see the IT:FDA Stock Forecast page.
More about Fidia Spa
Fidia S.p.A., based in Turin and listed on the Euronext Milan segment of Borsa Italiana, is a global leader in designing, producing, and marketing high-performance integrated milling systems. These systems are primarily used in the mold sector for the automotive and aerospace industries. With over 40 years of experience and approximately 135 employees, Fidia offers comprehensive solutions for the entire milling process, including numerical controls, high-speed milling systems, and CAM software.
Average Trading Volume: 575,618
Technical Sentiment Signal: Strong Sell
Current Market Cap: €3.72M
Learn more about FDA stock on TipRanks’ Stock Analysis page.